Clinical Trials Directory

Trials / Terminated

TerminatedNCT02894333

Action-effect Anticipation in Patients With Parkinson's Disease : A Study of the Sensory Attenuation Marker.

The Process of Sensory Anticipation in Patients With PARKINSON's Disease

Status
Terminated
Phase
Study type
Observational
Enrollment
1 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The ideomotor theory of action control is considered to be central to the understanding of human voluntary action. According to the ideomotor theory, an action is represented in terms of its desired sensory effects and actions are selected by internally activating these effect representations. Recent imagery and behavioral studies showed that this anticipated representation of action-effects triggered a "sensory attenuation", meaning a decrease of perceptive performances or a decrease of sensory event-related potentials (ERP) for an expected event. Thus, the sensory attenuation constitutes a relevant behavioral tool to investigate sensory anticipation impairment in patients with Parkinson's disease. In a behavioral paradigm, patients and matched control participants have to perform a perceptive task on predicted visual action-effects mixed with mispredicted visual action effects. Performances should be better in mispredicted visual action effects for control participants only.

Conditions

Interventions

TypeNameDescription
BEHAVIORALbehavioral observation

Timeline

Start date
2015-12-01
Primary completion
2018-09-01
Completion
2019-09-01
First posted
2016-09-09
Last updated
2019-12-23

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02894333. Inclusion in this directory is not an endorsement.